Ignite Creation Date:
2025-12-26 @ 11:46 AM
Ignite Modification Date:
2026-03-06 @ 8:58 AM
Study NCT ID:
NCT03211416
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-06-04
First Post:
2017-07-05
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Sorafenib Tosylate and Pembrolizumab in Treating Patients With Advanced or Metastatic Liver Cancer
Sponsor:
Roswell Park Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-12-07
Start Date Type:
ACTUAL
Primary Completion Date:
2023-03-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-12-07
Completion Date Type:
ESTIMATED
First Submit Date:
2017-07-05
First Submit QC Date:
None
Study First Post Date:
2017-07-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-04-30
Results First Submit QC Date:
None
Results First Post Date:
2024-05-29
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-23
Last Update Post Date:
2025-06-04
Last Update Post Date Type:
ACTUAL